Cinven to acquire Medpace in $900 million deal - Reuters

Private equity firm Cinven has agreed to acquire pharmaceutical contract research organization Medpace Inc from buyout firm CCMP Capital Advisors LLC for a little over $900 million, writes Reuters. Cinven and CCMP declined to comment, while a Medpace representative did not immediately respond to requests for comment.

DealsNorth AmericaUSBriefs